Summary
The medicine, called RK-251, turns on when it finds lots of tiny trouble‑making molecules inside cancer cells.
Tests on tiny fish showed the medicine can spot the bad cells without hurting the fish.
New drug named RK-251 is designed to become active only inside cancer cells.
It uses high levels of reactive oxygen molecules, which are common in cancer cells, to start working.
Early lab tests showed it killed cancer cells but did not harm normal cells.
The medicine is still being studied and not yet ready for people.
The medicine, called RK-251, turns on when it finds lots of tiny trouble‑making molecules inside cancer cells.
Tests on tiny fish showed the medicine can spot the bad cells without hurting the fish.
Want to learn even more? Click here to read the full story!